This from The Cell Culture Dish (via GEN) shows the Top 8 biologic drugs in 2012. They ranged from $4.0 B to $9.26 B, and all grew in sales in 2012. The stats appear below:
- Humira $9.26 B AbbVie
- Remicade $8.22 B Janssen & Merck
- Enbrel $7.96 B Amgen & Pfizer
- Rituxan $7.29 B Roche & Biogen Idec
- Lantus $6.65 B Sanofi
- Herceptin $6.40 B Roche
- Avastin $6.26 B Roche
- Neulasta $4.09 B Amgen
Roche and Amgen look like the leaders in the clubhouse. And of course, AbbVie's Humira took over title of top selling drug in the World.
Posted by Bruce Lehr Mar 18th 2013.
Comments